Skylar Jeremias

The University of Pittsburgh Medical Center (UPMC) Specialty Medical Home (SMH) model is redefining care for patients with inflammatory bowel disease (IBD) and behavioral health conditions by delivering integrated, patient-centered, team-based support.1 The approach addresses the physical and psychological complexity […]

Treatment options for children with hemophilia A have expanded with the FDA approval of Bayer’s Jivi antihemophilic factor (recombinant), PEGylated-aucl for the treatment of pediatric patients between 7 and 12 years of age.1 Hemophilia diagnosis is typically confirmed through specialized blood

Upadacitinib continues to show sustained long-term efficacy and a consistent safety profile in patients with moderate to severe ulcerative colitis, as confirmed by both clinical trial data and real-world evidence presented at Digestive Disease Week (DDW) 2025. Digestive Disease Week

As National Women’s Health Week approaches, a new study underscores the growing burden of female cancers worldwide.1 The global impact of breast, cervical, uterine, and ovarian cancers has risen significantly since 1990, and new projections warn that incidence rates for

While a gluten-free diet remains the primary treatment for celiac disease, careful nutritional management is essential to address both disease-related and diet-induced vitamin deficiencies, according to a review.1 The results highlight the risk of both disease-related and diet-induced vitamin deficiencies

Adults with irritable bowel syndrome (IBS) who smoke may face more challenges quitting, as severe IBS symptoms and high anxiety sensitivity increase perceived barriers to smoking cessation, make quitting more difficult, and strengthen the belief that smoking helps relieve negative

Despite being well tolerated with low discontinuation rates, there is a lack of strong evidence to confirm that exclusive enteral nutrition (EEN) is effective as an add-on therapy for active ulcerative colitis, highlighting the need for more robust research, according

Making the cost of inflammatory bowel disease (IBD) care sustainable requires improving access to cost-effective treatments, increasing biosimilar uptake, and implementing multidisciplinary care strategies to reduce both direct and indirect expenses, according to a recent review. Biosimilars offer cost-saving potential

Advancements in ocular technology, teleretinal imaging, and clinical management were key themes at the Southern Educational Congress of Optometry (SECO) 2025, held from February 26 to March 2 in Atlanta, Georgia. Research highlighted wearable ocular technologies like AI-powered smart glasses,

Emphasizing the need for effective communication, cultural competence, and accessibility in patient care are critical to addressing language barriers within eye care clinics, including challenges presented with communicating with non-native English speakers and nonverbal patients, according to a presentation at